The Safety, Dosimetry and Efficacy of 177Lu-INN805 in Patients With Malignant Solid Tumors
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
This study is a prospective, single-arm, open-label, dose-escalation study. A total of 4 dose groups were pre-defined in this study. The drug was administered once every 6 weeks.The drug would be administered for 1 to 4 cycles. The dosing schedule and dose could also be adjusted according to the patient's condition. After each dose group completed the enrollment and DLT observation, based on the participant's safety tolerance, radiation dosimetry, and preliminary efficacy evaluation results, it was decided whether to adjust the dose of the subsequent dose groups or to suspend the dose escalation.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Wiek 18-75 lat
- •Zaawansowany nowotwór, który nie odpowiedział na standardowe leczenie
- •Co najmniej jeden widoczny guz (rozpoznawalny w badaniach)
- •Ogólny stan zdrowia pozwalający na uczestnictwo (ECOG 0-1)
- •Wystarczająco wysokie wartości komórek krwi (hemoglobina, neutrofile, płytki)
- •Prawidłowe funkcje wątroby i nerek
✗ Disqualifies
- •Chemioterapia lub inne leczenie przeciwnowotworowe w ostatnich 4 tygodniach
- •Udział w innym badaniu klinicznym w ostatnich 4 tygodniach
- •Operacja w ostatnich 4 tygodniach
- •Skutki uboczne poprzedniego leczenia, które się nie ustąpiły
- •Przerzuty do mózgu powodujące objawy
- •Inne warunki, które badacz uzna za niekwalifikujące
Simplified criteria — AI translation
Trial details
- Minimum age
- 18 Years
- Maximum age
- 75 Years
- Last updated (source)
- September 4, 2026
- Sex
- No restrictions
Therapies / drugs in trial
Locations (1)
Affiliated Hospital of Jiangnan University
Wuxi, China
Trial contact
Tingjin Wang
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 9/5/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.